ArticleJournal of orthopaedic case reports2025
Functional Outcome of Hydrodilation in Adhesive Capsulitis of Shoulder.
Article in Journal of orthopaedic case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Adhesive capsulitis, or frozen shoulder, is a painful and disabling condition characterized by progressive restriction of shoulder movement. Hydrodilatation, a minimally invasive procedure involving joint capsule distension, has been proposed as an effective treatment option. This study evaluates the functional outcomes of hydrodilatation in patients with adhesive capsulitis using the Constant-Murley score (CMS) and American Shoulder and Elbow Surgeons (ASES) score, along with pre- and post-procedure range of motion (ROM) assessments. Materials and Methods: A prospective observational study was conducted on 30 patients diagnosed with adhesive capsulitis who underwent hydrodilatation. Functional and ROM improvements were assessed at baseline, post-procedure, 1 month, 3 months, 6 months, and 1 year. Data were analyzed using paired t-tests, and P < 0.05 was considered statistically significant. Results: The mean age of participants was 47.7 ± 9.8 years. The study population comprised 14 males (46.7%) and 16 females (53.3%), indicating a slightly higher prevalence among females. Significant improvements were observed in active and passive abduction, adduction, forward flexion, and external rotation (P < 0.001). Internal rotation restriction reduced from 59.1% to 40.9% (P < 0.001). Functional scores (ASES and CMS) showed progressive improvement, with ASES increasing from 41.1 ± 6.1 to 65.9 ± 8.4 and CMS from 44.4 ± 5.8 to 64.8 ± 9.1 at 1 year (P < 0.001). Conclusion: Hydrodilatation is an effective and well-tolerated intervention for improving shoulder function in adhesive capsulitis, with sustained benefits up to 1 year. Future studies should focus on standardizing treatment protocols and optimizing patient selection criteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.